ケニアにおけるバイオマス燃焼による室内大気汚染と急性呼吸器感染症:エクスポージャーレスポンス研究
関連する実験動画
Updated: Jul 19, 2026

10:11
Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
1Center for Risk Management, Resources for the Future, Washington, DC, USA. ezzati@rff.org
Lancet (London, England)
|September 1, 2001
まとめ
バイオマス燃料の煙に曝露すると,急性呼吸器感染症 (ARI) のリスクが著しく増加し,特にPMの1000〜2000 mg/m3以下 (10). この曝露を減らすことは,世界的に公衆衛生上の実質的な利益をもたらします.
科学分野:
- 環境の健康 環境の健康
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
背景:
- 急性呼吸器感染症 (ARI) は,開発途上国の国内バイオマス燃料の汚染と密接に関連した,主要な世界的な健康上の負担です.
- バイオマス燃料の燃焼は,10マイクロメートル未満の粒子物質 (PM10),重要な環境汚染物質を放出します.
研究 の 目的:
- バイオマス燃料からのPM10とARI/ALRIの曝露-反応関係を定量化する.
- 室内大気汚染の影響を軽減することを目的とした公衆衛生政策と介入の情報提供.
主な方法:
- ケニアの農村部の55世帯の縦断的な健康データを2年間にわたって収集した.
- 毎週の臨床検査で,ARIと急性下呼吸器感染症 (ALRI) の発生率をモニタリングしました.
- 個人のPM10暴露は,排出量濃度測定と時間活動予算によって評価されました.
主要な成果:
- ARIとALRIの発生率は,日平均PM10曝露とともに増加し,凸な曝露-反応曲線を示した.
- ARI/ALRIの増加率は,PM10への曝露が1000〜2000mg/mを超えると減少した[3].
- 高強度被曝エピソードが考慮されたとき,性別はARI/ALRIの有意な予測要因ではなかった.
結論:
- PM10の露出を減らすことは,1000〜2000mg/m以下でより大きな健康上の利益をもたらす.
- 発見は,国際公衆衛生戦略,エネルギー研究,20億人以上に影響を与える技術移転に重大な影響を及ぼします.
関連する概念動画
Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

